PL1885383T3 - Kocie probiotyczne bifidobakterie - Google Patents

Kocie probiotyczne bifidobakterie

Info

Publication number
PL1885383T3
PL1885383T3 PL06734378T PL06734378T PL1885383T3 PL 1885383 T3 PL1885383 T3 PL 1885383T3 PL 06734378 T PL06734378 T PL 06734378T PL 06734378 T PL06734378 T PL 06734378T PL 1885383 T3 PL1885383 T3 PL 1885383T3
Authority
PL
Poland
Prior art keywords
probiotic bifidobacteria
feline
feline probiotic
bifidobacteria
probiotic
Prior art date
Application number
PL06734378T
Other languages
English (en)
Inventor
Thomas William-Maxwell Boileau
Barry Pius Kiely
Liam Diarmuid O'mahony
John Macsharry
Gregory Dean Sunvold
Original Assignee
Iams Europe B.V.
Alimentary Health Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Europe B.V., Alimentary Health Limited filed Critical Iams Europe B.V.
Publication of PL1885383T3 publication Critical patent/PL1885383T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
PL06734378T 2005-05-31 2006-02-02 Kocie probiotyczne bifidobakterie PL1885383T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68601605P 2005-05-31 2005-05-31
US69243905P 2005-06-21 2005-06-21

Publications (1)

Publication Number Publication Date
PL1885383T3 true PL1885383T3 (pl) 2017-06-30

Family

ID=36823890

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06734378T PL1885383T3 (pl) 2005-05-31 2006-02-02 Kocie probiotyczne bifidobakterie

Country Status (10)

Country Link
US (2) US8034601B2 (pl)
EP (1) EP1885383B1 (pl)
JP (1) JP4938006B2 (pl)
AR (1) AR053805A1 (pl)
AU (1) AU2006253007B2 (pl)
BR (1) BRPI0611492B1 (pl)
CA (1) CA2607949C (pl)
ES (1) ES2607988T3 (pl)
PL (1) PL1885383T3 (pl)
WO (1) WO2006130188A1 (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
WO2008053444A2 (en) * 2006-11-01 2008-05-08 The Procter & Gamble Company Treating a respiratory condition with bifidobacterium
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
GB2460781B (en) * 2007-03-28 2012-01-25 Alimentary Health Ltd Probiotic bifidobacterium strains
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
MX2011002735A (es) * 2008-09-11 2011-04-12 Iams Company Alimento granulado para animales que tiene un nucleo basado en proteinas y metodos relacionados.
WO2010138372A2 (en) 2009-05-28 2010-12-02 The Iams Company Pet food in the form of a coated kibble
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9210945B2 (en) 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP5431597B2 (ja) 2010-01-22 2014-03-05 ザ・アイムス・カンパニー コーティングされたキブルの形態でペットフードを製造する方法
CA2697758A1 (en) * 2010-03-24 2011-09-24 Normerica Inc. Food composition comprising germinated seeds or grains
FR2959128B1 (fr) * 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
PL2481299T3 (pl) * 2011-01-31 2017-09-29 Synformulas Gmbh Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US9125935B1 (en) * 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
WO2013095323A1 (en) 2011-12-19 2013-06-27 Hill's Pet Nutrition, Inc. Highly digestible pet food for improving stool quality
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014082050A1 (en) 2012-11-23 2014-05-30 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2956006A4 (en) 2013-02-04 2017-02-22 Seres Therapeutics, Inc. Methods of populating a gastrointestinal tract
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
WO2015077794A1 (en) 2013-11-25 2015-05-28 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US20150173397A1 (en) * 2013-12-20 2015-06-25 The Lams Company Pet food composition having probiotic bifidobacterium animalis
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
BR112017017190B1 (pt) 2015-02-16 2022-08-30 Mars, Incorporated Método para produzir um alimento para animais de estimação
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
AU2016282996A1 (en) 2015-06-25 2018-01-18 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
MX2018008492A (es) 2016-01-07 2018-08-23 Ascus Biosciences Inc Metodos para mejorar la produccion de leche mediante la administracion de consorcios microbianos.
MX2019007760A (es) 2016-12-28 2020-02-10 Ascus Biosciences Inc Metodos, aparatos y sistemas para analisis de cepa de microorganismo de comunidades heterogeneas complejas con analisis rastreador, determinacion de relaciones funcionales e interacciones de estas, y sintesis de agrupaciones microbianas que incluyen agrupaciones microbianas dosificadas y agrupaciones microbianas inoculativas.
EP3562954A1 (en) 2016-12-28 2019-11-06 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
MX2019012680A (es) 2017-04-28 2019-12-11 Ascus Biosciences Inc Metodos para complementar dietas con alto consumo de granos y/o alto valor energetico en rumiantes, mediante la administracion de un bioensamble sintetico de microbios, o cepas purificadas de los mismos.
AU2018318132A1 (en) 2017-08-14 2020-02-27 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN114283890B (zh) * 2021-12-15 2023-04-07 南京医科大学 一种基于瘤胃球菌微生物群的疾病风险预测装置
CN114574542B (zh) * 2021-12-15 2023-01-31 南京医科大学 瘤胃球菌微生物群评估生物年龄的用途
WO2023235846A2 (en) * 2022-06-03 2023-12-07 Petri Bio, Inc. Methods and compositions for methionine restriction

Family Cites Families (394)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US571521A (en) 1896-11-17 Package for powders
US1086936A (en) 1913-05-15 1914-02-10 Malcolm Pounder Dental massage implement.
US1503094A (en) 1923-09-15 1924-07-29 Cramerton Mills Inc Warp condenser
US2473773A (en) 1945-11-16 1949-06-21 Eleanor Kushmaul Toothbrush
US2540979A (en) * 1948-04-24 1951-02-06 Smith Kline French Lab Enteric coating
US2641548A (en) 1950-04-06 1953-06-09 Helen W Heinrich Method of preserving avocados
NL294835A (pl) * 1962-07-19 1900-01-01
US3398001A (en) 1963-04-26 1968-08-20 Air Reduction Process of preparing and packaging frozen avocados
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1190387A (en) 1966-05-24 1970-05-06 Green Cross Corp Enteric Coated Medicaments
DE1536074A1 (de) 1966-06-28 1969-11-13 Hoefliger & Karg Tiefziehpackung
US3677898A (en) * 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US3898132A (en) * 1972-08-24 1975-08-05 Int Feed Improvement Ass Inc Method of preparing stowable, dormant bacteria
US3931885A (en) 1973-04-30 1976-01-13 Nahill Edmond P Medicine dispensing system
US3897572A (en) 1973-05-16 1975-07-29 Star Kist Foods Formed meat product
US3989822A (en) 1974-02-14 1976-11-02 Purdue Research Foundation Weight control compound
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS6038372B2 (ja) 1975-04-09 1985-08-31 日清製粉株式会社 犬の下痢予防および治療方法
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
GB1595054A (en) 1977-11-14 1981-08-05 Metal Box Co Ltd Capsules containing micro-organisms
IL58649A (en) 1978-11-10 1982-04-30 Beecham Group Ltd Pharmaceutical dispensing container
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4338346A (en) * 1978-12-21 1982-07-06 The Procter & Gamble Company Non-nutritive sweetener
FR2453215A1 (fr) * 1979-04-05 1980-10-31 Rhone Poulenc Ind Procede d'inclusion de micro-organismes dans une matrice de polymere
US4248857A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4411925A (en) * 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4399163A (en) * 1980-11-05 1983-08-16 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4423029A (en) * 1981-06-25 1983-12-27 The Procter & Gamble Company (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners
US4403623A (en) 1981-11-16 1983-09-13 Colgate-Palmolive Company Combined toothbrush and gum massage device
DE3221425A1 (de) 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
JPS6024153Y2 (ja) 1982-07-20 1985-07-18 山陽菓機工業有限会社 食品製造工程に於る油塗布装置
NL8203297A (nl) 1982-08-24 1984-03-16 Philips Nv Weerstandslichaam.
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
JPS59213368A (ja) 1983-05-17 1984-12-03 Hanamaruki Kk 果実食品およびその製造法
US4736849A (en) 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
CA1276394C (en) 1984-07-13 1990-11-13 John M. Janusz Alpha-l-aspartyl-d-phenylglycine esters and amides useful as high intensity sweeteners
US4647453A (en) 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
JPS61109729A (ja) 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
EP0212746B1 (en) 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
EP0212747B1 (en) 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
US4764389A (en) 1986-04-24 1988-08-16 Labarge Universal Ripener, Inc. Method of accelerating fruit respiration
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
JPH041402Y2 (pl) 1986-06-16 1992-01-17
CA1300538C (en) 1986-08-01 1992-05-12 Robert Charley Maintenance of the viability of microorganisms for use in microbial inoculants
US4808626A (en) 1986-09-23 1989-02-28 Monell Chemical Senses Center Use of 2,5-anhydro-D-mannitol as a food intake modifier
US4781939A (en) * 1986-10-28 1988-11-01 Nestec, S.A. Layered meat emulsion product and method of producing same
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4797289A (en) * 1987-03-09 1989-01-10 Reddy Malireddy S Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
AU620807B2 (en) 1987-05-01 1992-02-27 Biogaia Biologics Ab Antibiotic reuterin
DE3715070A1 (de) 1987-05-06 1988-11-17 Kneipp Werke Kneipp Mittel Zen Verfahren zur herstellung von pflanzenauszuegen, insbesondere von pflanzensaeften
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2615203B1 (fr) 1987-05-12 1989-08-18 Agronomique Inst Nat Rech Inoculum dans lequel les micro-organismes sont conditionnes sous la forme de granules biodegradables, son procede de preparation et ses applications
GB8713601D0 (en) 1987-06-10 1987-07-15 Unilever Plc Fermentation
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US4937077A (en) 1987-09-21 1990-06-26 Eastman Kodak Company Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
US4814193A (en) 1988-04-06 1989-03-21 General Foods Corporation Reduction of microbial population on surface of food materials
JPH01278781A (ja) 1988-05-02 1989-11-09 Nec Corp 不揮発性半導体記憶装置
US5126153A (en) 1988-05-13 1992-06-30 Basic American Foods, Inc. Compositions and methods for inhibiting browning of processed produce
WO1990001335A1 (en) 1988-08-02 1990-02-22 Borody Thomas J Treatment of gastro-intestinal disorders
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US4889238A (en) 1989-04-03 1989-12-26 The Procter & Gamble Company Medicament package for increasing compliance with complex therapeutic regimens
AU5254790A (en) 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
US5540945A (en) * 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
PT94108A (pt) 1989-05-24 1991-02-08 Asahi Chemical Ind Preparacao de microorganismos viaveis contendo esporos estabilizada,sua producao e pilulas respectivas
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DE3933528C1 (pl) * 1989-10-04 1990-12-06 Effem Gmbh, 2810 Verden, De
SE465206B (sv) * 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5344824A (en) * 1990-02-02 1994-09-06 Matsutani Chemical Industries Co., Ltd. Method for reducing insulin secretion
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
DK203090A (da) 1990-02-28 1991-08-29 Sitia Yomo Spa Maelkeagtig mousse, dens tilberedning og anvendelse
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
DE4018392A1 (de) 1990-06-08 1991-12-12 Kaysan Rolf Dipl Kaufm Verfahren zur gewinnung von pflanzen-hydrolysaten insbesondere fuer biokosmetische und pharmazeutische zwecke
FR2663198B1 (fr) 1990-06-14 1993-09-17 Xeda International Utilisation de composes antioxydants pour augmenter la resistance des fruits et legumes contre les infections fongiques.
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
FR2668081B1 (fr) 1990-10-19 1994-11-18 Lvmh Rech Procede et appareil de fabrication de particules solides a partir d'un materiau solidifiable en presence d'un agent de solidification en de bons rendements.
US5292657A (en) 1990-12-31 1994-03-08 Pioneer Hi-Bred International, Inc. Process for preparing rotary disc fatty acid microspheres of microorganisms
IT1244691B (it) 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
WO1993002558A1 (en) 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
GB2261372A (en) 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
EP0563934A1 (de) 1992-04-03 1993-10-06 Dr. Karl Thomae GmbH Blisterstreifen aus Kunststoff-Folien mit Doppel-bzw. Mehrfachdosierung.
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
EP0768375B2 (fr) 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
US5501857A (en) 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
TW243415B (pl) 1992-08-20 1995-03-21 Schering Corp
US5403799A (en) * 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
EP0706400A1 (en) 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
BR9405999A (pt) 1993-03-16 1995-12-19 Us Agriculture Flora de exclusão competitiva relativa à mucosa
IT1265092B1 (it) 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
GB9315846D0 (en) 1993-07-30 1993-09-15 Isis Innovation Tumour inhibitors
GB9318439D0 (en) 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
US5501868A (en) 1993-09-21 1996-03-26 Colgate Palmolive Company Extruded dog treat food product having improved resistance to breakage
DE4336050C2 (de) 1993-10-22 1995-11-16 Onken Gmbh Tierfutter, insbesondere Alleinfutter für Katzen und Hunde
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
JPH07232049A (ja) 1994-02-25 1995-09-05 Freunt Ind Co Ltd 遠心転動造粒コーティング装置および粉粒体の遠心転動造粒コーティング方法ならびにその方法を用いた粉粒体の造粒方法とコーティング方法
JP2992945B2 (ja) 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
US5894029A (en) 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
SE9401738D0 (sv) 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
IT1270216B (it) 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5733540A (en) * 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FI102298B1 (fi) 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään soveltuvia oligonukleotideja
US5702679A (en) 1995-10-06 1997-12-30 Kerr-Mcgee Chemical Corp. Method of preparing Li1+X- Mn2-X O4 for use as secondary battery
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
AT405235B (de) 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
AUPN698495A0 (en) 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
US5858356A (en) 1995-12-21 1999-01-12 Abbott Laboratories Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals
US5854067A (en) 1996-01-19 1998-12-29 Board Of Regents, The University Of Texas System Hexokinase inhibitors
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
GB2311027B (en) 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
RU2086248C1 (ru) 1996-04-02 1997-08-10 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Пробиотический препарат "стрептобифид" для животных
US5824779A (en) 1996-04-26 1998-10-20 Wisconsin Alumni Research Foundation Phytase-protein-pigmenting concentrate derived from green plant juice
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
ATE298363T1 (de) 1996-07-09 2005-07-15 Nestle Sa Verfahren zur sprühtrocknung
US5871794A (en) 1996-08-07 1999-02-16 Brito; Jorge Issac Stabilized guacamole and method for making same
US5660790A (en) * 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
AU744156B2 (en) 1996-10-28 2002-02-14 General Mills Inc. Embedding and encapsulation of controlled release particles
CA2271930C (en) 1996-11-29 2006-10-17 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
WO1998027967A1 (en) 1996-12-20 1998-07-02 Dumex-Alpharma A/S Release-controlled coated tablets
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
JP4743925B2 (ja) 1997-02-11 2011-08-10 エンタープライズ アイルランド トレーディング アズ バイオリサーチ アイルランド ラクトバシラス・サリバリウス由来の生体に有益な菌株及びそれより得られた抗菌剤
AU2809899A (en) 1997-03-18 1999-07-22 Mendel Institute For Nutraceutical Research Inc, The Dosing beverage with a bacteria formulation
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
AU749001B2 (en) 1997-04-18 2002-06-13 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
AU750136B2 (en) 1997-06-03 2002-07-11 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
IT1292636B1 (it) 1997-06-20 1999-02-08 Ascor Chimici Srl Composizione a rilascio controllato di sostanze biologicamente attive ad uso zootecnico.
RU2123343C1 (ru) 1997-06-26 1998-12-20 Алин Борис Иннокентьевич Способ получения капсул, содержащих бактерии b.bifidum (бифидумбактерин сухой в капсулах)
US5976579A (en) * 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
AU743914B2 (en) 1997-07-05 2002-02-07 Societe Des Produits Nestle S.A. Absorption of minerals by intestinal cells
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20180000880A9 (en) 1997-07-08 2018-01-04 The Iams Company Methods of treating or preventing overweight and obsesity in mammals by administering a composition comprising mannoheptulose
US20020035071A1 (en) 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6077530A (en) 1997-07-28 2000-06-20 Weinstein; Robert Analgesic dosage units for coordinated administration
SE510753C2 (sv) 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
US5939117A (en) 1997-08-11 1999-08-17 Mantrose-Haeuser Co., Inc. Methods for preserving fresh fruit and product thereof
US6063414A (en) 1997-08-18 2000-05-16 Seal Rock Technologies Incorporated Combination container and dry pet food for increased shelf life, freshness, palatability, and nutritional value
FI108512B (fi) 1997-08-22 2002-02-15 Danisco Finland Oy Tahnamainen nautittavaksi tarkoitettu koostumus, sen käyttö ja sitä sisältävät tuotteet
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
JP3400685B2 (ja) 1997-09-04 2003-04-28 矢崎総業株式会社 インサート成形によるターミナルの製造方法
SE511025C2 (sv) 1997-10-03 1999-07-26 Probi Ab Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
KR100387245B1 (ko) 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
US5871802A (en) 1997-12-16 1999-02-16 Moorman Manufacturing Co. Animal feed pelleting process and animal feed pellets produced therefrom
AR014129A1 (es) 1997-12-17 2001-02-07 Nutrasweet Co Bebida que comprende fundamentalmente un ester n-[n-(3,3-dimetilbutil)-l- alfa-aspartil]-l-fenilamina 1 - metilico, bebida sin alcohol carbonatada,bebida de jugo, bebida envasada caliente y bebida deportiva de bajas calorias.
PT931543E (pt) 1997-12-19 2002-09-30 Merck Patent Gmbh Comprimidos de varias camadas contendo microorganismos probioticos como por exemplo lactobacilus ou bifidobacterias
IT1298918B1 (it) 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
PE20000601A1 (es) 1998-03-23 2000-07-25 Gen Mills Inc Encapsulado de componentes en productos comestibles
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
FI104405B (fi) 1998-03-27 2000-01-31 Valtion Teknillinen Mikro-organismeja sisältävät tärkkelyskapselit ja niiden valmistusmenetelmä
US5932258A (en) 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
EP0956858B1 (en) 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections
DE19819475A1 (de) 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
AU4549699A (en) 1998-07-30 2000-02-21 Warner-Lambert Company Centerfill delivery system for nutraceuticals
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US6156355A (en) 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP2000191519A (ja) 1998-12-25 2000-07-11 Nippon Kayaku Co Ltd 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
DE19860375A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6767573B1 (en) 1999-03-10 2004-07-27 Nestec S.A. Fried pet treats
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US6692779B2 (en) 1999-03-26 2004-02-17 The Pillsbury Company Food products with biocontrol preservation
US6358555B1 (en) 1999-03-31 2002-03-19 Hideyuki Takahashi Process for producing frozen avocados
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
AU767764C (en) * 1999-05-27 2005-08-18 Mars, Incorporated Process and product for enhancing immune response in companion animal using a combination of antioxidants
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US6375956B1 (en) 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
DE19937361A1 (de) 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
US6737089B2 (en) 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
ES2307531T3 (es) 1999-09-07 2008-12-01 Societe Des Produits Nestle S.A. Metodo para mejorar la piel y el pelaje de los animales de compañia.
BR0007166A (pt) 1999-09-22 2001-07-31 Nestle Sa Método para aumentar a atividade dos animais de estimação
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
MXPA02004115A (es) 1999-10-26 2002-10-17 Nestle Sa Bacterias acidolacticas para el tratamiento o profilaxis de giardiasis.
US6394803B1 (en) 1999-12-09 2002-05-28 Ivoclar Ag Mixing arrangement
EP1239885B1 (en) 1999-12-23 2008-06-11 The Regents of the University of California Interventions to mimic the effects of calorie restriction
US6406853B1 (en) 1999-12-23 2002-06-18 The Regents Of The University Of California Interventions to mimic the effects of calorie restriction
JP5148796B2 (ja) 2000-01-18 2013-02-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットのヘリコバクター種治療用ペットフード組成物
US20010036488A1 (en) 2000-01-18 2001-11-01 Syuichi Hayashi Anti-obestic composition
US20030060503A1 (en) 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
JP2001309753A (ja) 2000-04-28 2001-11-06 Natl Fedelation Of Agricult Coop Assoc 犬特有の感染症の予防・治療用ドッグフード
US20030104090A1 (en) 2000-05-05 2003-06-05 Levy Pedro E. Supplements containing annatto extracts and carotenoids and methods for using the same
NZ523010A (en) * 2000-05-25 2004-06-25 Nestle Sa Lactic acid bacteria strains and their use as probotics for pet food
FR2809312B1 (fr) 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US6571229B1 (en) 2000-05-31 2003-05-27 Motorola, Inc. Method and apparatus for inerative training of a classification system
DE10029079B4 (de) 2000-06-13 2006-04-20 Mars Inc. Probiotische Mikroorganismen enthaltendes Nahrungsmittelerzeugnis
US6746672B2 (en) 2000-06-19 2004-06-08 Regents Of The University Of Minnesota Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis
CA2416120A1 (en) 2000-07-17 2002-01-24 Svend Laulund Methods and formulations with probiotic microorganisms and medicaments
JP4873824B2 (ja) 2000-08-01 2012-02-08 オリザ油化株式会社 糖質吸収阻害剤およびその製造方法
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
ES2316463T3 (es) 2000-08-25 2009-04-16 Wakamoto Pharmaceutical Co., Ltd. Productos probioticos que contienen la cepa l.salivarius.
NZ524527A (en) 2000-09-25 2005-05-27 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
EP1593382A1 (en) 2000-10-06 2005-11-09 Société des Produits Nestlé S.A. Use of probiotic lactic bacteria for balancing the skin's immune system
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6802422B2 (en) 2000-12-12 2004-10-12 Multi-Comp, Inc. Sealed blister assembly
WO2002058712A2 (en) 2000-12-18 2002-08-01 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01
KR20020050048A (ko) 2000-12-20 2002-06-26 박흥재 Lactobacillus sp.DW-1 동정 시스템
US20020119237A1 (en) 2000-12-22 2002-08-29 Hevey Maurice O. Medium and method for delivery of edible materials subject to degradation by oxidation and hydrolysis
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030190314A1 (en) 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
US6588180B2 (en) 2001-02-02 2003-07-08 R. P. Scherer Technologies, Inc. Constricted neck blister pack and apparatus and method for making the same
AU2002250886B2 (en) 2001-02-06 2007-08-02 Societe Des Produits Nestle S.A. Endotoxin binding by lactic acid bacteria and bifidobacteria
PL205155B1 (pl) 2001-02-19 2010-03-31 Nestle Sa Jadalny suchy produkt oraz sposób jego wytwarzania
US6586027B2 (en) 2001-02-23 2003-07-01 T.F.H. Publications, Inc. Health chew toy
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
CN1638650A (zh) 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
EP1372614A4 (en) * 2001-03-16 2007-10-31 Andrx Pharmaceuticals Llc SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
EP1373475A2 (en) 2001-04-02 2004-01-02 Alimentary Health Limited Immunotherapy based on dendritic cells
WO2002085415A1 (en) * 2001-04-17 2002-10-31 Biomatrix, Inc Non-digestible sugar-coated products and process
EP1260227A1 (en) 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
US7081478B2 (en) 2001-06-29 2006-07-25 Chrysantis, Inc. Mixed zeaxanthin ester concentrate and uses thereof
EP1277412A1 (en) 2001-07-17 2003-01-22 Societe Des Produits Nestle S.A. Pet food composition for regulating body weight and preventing obesity and related disorders in pets
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
PE20030283A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US7666459B2 (en) 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
MXPA04002511A (es) 2001-09-18 2004-05-31 Nestec Sa Producto de alimento para mascota y metodo de manufactura.
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US6624162B2 (en) 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators
US20050164978A1 (en) 2001-10-26 2005-07-28 Chapnick David I. Method for normalizing insulin levels
US6896914B2 (en) * 2001-10-26 2005-05-24 David I. Chapnick Method for normalizing insulin levels
AU2002339112B2 (en) 2001-11-12 2007-10-11 Mars, Incorporated Foodstuff
EP1448213A2 (en) 2001-11-16 2004-08-25 Novartis Nutrition AG Plant derived or derivable material with appetite suppressant activity
JP4999037B2 (ja) 2001-11-23 2012-08-15 ワーナー チルコット カンパニー リミテッド ライアビリティ カンパニー 複数のコーティングを有する医薬剤形
EP1319410A1 (en) 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
NZ512778A (en) * 2002-01-05 2004-08-27 Silentnite 02 Company Ltd A toilet with water supplied directly from mains supply (no cistern), having a venturi effect inducing water inlet at the base/rear of the bowl and also rim mounted jets orientated to provide a clockwise 'rinsing' of the bowl.
ATE387858T1 (de) 2002-01-15 2008-03-15 Mars Inc Verfahren und damit hergestellte produkte für die stabilisierung von mehrschichtigen nahrungsmittelprodukten
US20030143293A1 (en) 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
WO2003070260A1 (en) 2002-02-21 2003-08-28 Societe Des Produits Nestle S.A. A photoprotective orally administrable composition for skin
EP1344458A1 (en) 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
DE10217970A1 (de) 2002-04-22 2003-11-13 Henkel Kgaa Durchdrückverpackung
DE10213280A1 (de) 2002-03-25 2003-10-23 Mars Inc Proteinhaltiges Nahrungsmittelerzeugnis und Verfahren zu seiner Herstellung
US6681935B1 (en) 2002-04-02 2004-01-27 Graham L. Lewis Method of providing a therapeutic regimen and prefabricated container therefor
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
US20030194423A1 (en) 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US6733795B2 (en) 2002-07-30 2004-05-11 Laboratoires Expanscience Method for producing an avocado leaf extract rich in furanic lipids
US20050208163A1 (en) 2002-07-31 2005-09-22 Brovelli Ernesto A Compositions containing avocado leaf extract for lowering cholesterol levels
KR20040024774A (ko) 2002-09-16 2004-03-22 이성표 혈액형별 체질에 적합하도록 제조한 생약 조성물
JP2004173675A (ja) 2002-10-02 2004-06-24 Takayuki Hirano 耐化学剤性を有する菌封入物および製造方法
AU2003274572A1 (en) 2002-11-15 2004-06-15 Warner-Lambert Company Llc Method of lowering crp and reducing systemic inflammation
US7179460B2 (en) 2002-12-05 2007-02-20 Danisco A/S Bacterial composition and its use
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
CA2513399A1 (en) 2003-01-10 2004-07-29 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose
US7122370B2 (en) 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
JP2006523214A (ja) 2003-03-21 2006-10-12 ジユーリー，マデレーン・エム タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法
DE60325104D1 (de) 2003-03-25 2009-01-15 Gen Mills Inc Verfahren zur behandlung von avocado und verfahren zur herstellung von guacamole
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
US20040234579A1 (en) 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
FR2855374B1 (fr) 2003-05-26 2007-06-01 Roquette Freres Procede de drageification dure ameliore
US20060147962A1 (en) 2003-06-16 2006-07-06 Mars, Inc. Genotype test
WO2004112509A2 (en) 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
EP2289504A3 (en) 2003-07-01 2012-05-23 President and Fellows of Harvard College SIRT1 modulators for manipulating cell/organism lifespan/stress response
US7235276B2 (en) 2003-09-24 2007-06-26 General Mills Ip Holdings Ii, Llc High protein puffed food product and method of preparation
US20050074519A1 (en) 2003-10-01 2005-04-07 Sensient Flavors Inc. Method for the production of natural botanical extracts
GB0323668D0 (en) 2003-10-09 2003-11-12 Nestec Sa Fat-based confectionery product coated with a film forming agent making it resistant to heat and shape stable to heat
US20050100559A1 (en) 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7687077B2 (en) 2003-11-26 2010-03-30 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
US20050112259A1 (en) 2003-11-26 2005-05-26 Fernando Qvyjt Pet food composition having enhanced palatability
MXPA06006773A (es) 2003-12-18 2006-09-04 Nestec Sa Composicion para mejorar la salud de la piel, el cabello y el pelo, que contiene flavanonas.
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
TW200524539A (en) 2003-12-23 2005-08-01 Rohm & Haas A method to reverse ethylene inhibitor responses in plants
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
DE102004004030A1 (de) 2004-01-27 2005-08-18 Mars Inc. Nahrungsmittelerzeugnis und Verfahren zu dessen Herstellung
WO2005089436A2 (en) 2004-03-16 2005-09-29 The Regents Of The University Of California Genetic networks regulated by attenuated gh/igf1 signaling and caloric restriction
GB0406654D0 (en) 2004-03-24 2004-04-28 Mars Inc Foodstuff
CN1997748A (zh) 2004-04-20 2007-07-11 芝加哥大学 来自乳杆菌gg的益生化合物及其用途
FR2869543B1 (fr) 2004-04-30 2006-07-28 Expanscience Laboratoires Sa Medicament comprenant un extrait peptidique d'avocat destine au traitement et la prevention des maladies liees a une deficience du systeme immunitaire
FR2869541B1 (fr) 2004-04-30 2007-12-28 Expanscience Sa Lab Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
US9089576B2 (en) 2004-04-30 2015-07-28 Laboratoires Expanscience Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
US20050249837A1 (en) 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
CA2569249C (en) 2004-05-10 2012-08-14 The Iams Company Processes for preparing plant matter extracts and pet food compositions
US20090252834A1 (en) 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
EP1750674A4 (en) 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
JP2005348698A (ja) 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk ケフィア粒から分離された微生物とこの微生物あるいはそれを含む微生物群を培養して得られる微生物培養物ならびにそれらを用いた製品
AU2005258021B2 (en) 2004-06-17 2008-12-18 Wisconsin Alumni Research Foundation Compounds and methods for treating seizure and paroxysmal disorders
EP1771091B1 (en) 2004-07-01 2017-11-08 Nestec S.A. Canine osteoarthritis diet formulation
WO2006007463A1 (en) 2004-07-01 2006-01-19 General Mills, Inc. Cultures encapsulated with compound fat breakfast cereals coated with compound fat and methods of preparation
US20060008511A1 (en) 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US7935334B2 (en) 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060029685A1 (en) 2004-07-30 2006-02-09 Henderson Todd R Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
US20060070895A1 (en) 2004-08-16 2006-04-06 Faisal Khawaja Drug administration kit
JP2006055145A (ja) 2004-08-19 2006-03-02 Kosshi:Kk ペットフード及びペットフードの提供方法
ES2304585T3 (es) 2004-09-21 2008-10-16 Nestec S.A. Longevidad mejorada de gatos de avanzada edad.
US20070286935A1 (en) 2004-10-07 2007-12-13 Nestec S.A. Bioactive Compositions, Natural Methods of Producing Them and Computational Methods for Designing Natural Production Processes
FR2876876B1 (fr) 2004-10-22 2007-02-16 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par l'utilisation de microorganismes presentant une capacite de metabolisation reduite
FR2876875B1 (fr) 2004-10-22 2007-02-02 Gervais Danone Sa Protection d'ingredients alimentaires bioactifs par encapsulation
WO2006066244A2 (en) 2004-12-17 2006-06-22 Cash Alan B Method for extending lifespan and delaying the onset of age-related disease
BRPI0607930A2 (pt) 2005-02-10 2010-11-09 Firmenich & Cie método para preparar um produto alimentìcio compreendendo aromas, e, produto alimentìcio
US20060228459A1 (en) 2005-04-11 2006-10-12 The Iams Company Compositions comprising a cocoa butter component and an animal-derived fat component
US20100233312A9 (en) 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060228448A1 (en) 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
BRPI0609388A2 (pt) 2005-05-11 2011-10-18 Hills Pet Nutrition Inc composição, métodos para realçar a palatabilidade de uma composição para o consumo por um animal, para aumentar a freqüência de ingestão ou a taxa de ingestão de uma composição e para fabricar uma composição, produto, kit, e, meio para comunicar informação sobre ou instruções para misturar e administrar uma composição
EP1881767B1 (en) 2005-05-13 2017-03-29 Hill's Pet Nutrition, Inc. Dry food compositions having enhanced palatability
US9480275B2 (en) 2005-05-20 2016-11-01 Mars Incorporated Coated pet food products
WO2006127424A2 (en) 2005-05-20 2006-11-30 Hill's Pet Nutrition, Inc. Methods for promoting health or wellness in adult animals
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
JP5546126B2 (ja) 2005-06-01 2014-07-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物消費用組成物の嗜好性を高める方法
AT501919B1 (de) 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
US20070009577A1 (en) 2005-07-05 2007-01-11 Mankovitz Roy J Probiotic compositions and methods
US20070149466A1 (en) 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
RU2402919C2 (ru) 2005-07-14 2010-11-10 Хилл'С Пет Ньютришн, Инк. Способ продления жизни животных
US20070122531A1 (en) 2005-09-01 2007-05-31 Wellmark International Methods for Selecting a Pet-Appropriate Product
US8865197B2 (en) 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
GB0519164D0 (en) 2005-09-20 2005-10-26 Mars Inc Composition
RU2388320C2 (ru) 2005-09-30 2010-05-10 Хилл'С Пет Ньютришн, Инк. Способы увеличения срока хранения пищевых композиций, содержащих полиненасыщенные жирные кислоты
JP4198728B2 (ja) 2005-09-30 2008-12-17 株式会社グローバルエンジニアリング 動物用免疫活性調整剤、及びその調整剤を含有する動物用飼料
EP1931364B1 (en) 2005-10-06 2010-07-21 Nestec S.A. Probiotic enterococci for improved immunity
US20070280964A1 (en) 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
US20070082107A1 (en) 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
CA2624849A1 (en) 2005-10-19 2007-04-26 Hill's Pet Nutrition, Inc. Methods and compositions for improving gastrointestinal health
US7647098B2 (en) 2005-10-31 2010-01-12 New York University System and method for prediction of cognitive decline
CA2626735C (en) 2005-11-04 2013-07-16 Hill's Pet Nutrition, Inc. Methods and compositions for improving stool quality
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
WO2007060539A2 (en) 2005-11-28 2007-05-31 Jorrocks Pty Ltd. Methods for preparation of animal feeds
CN101321556A (zh) 2005-12-02 2008-12-10 希尔氏宠物营养品公司 改变粪便质量和/或粪便频率的方法
CA2635038A1 (en) 2005-12-29 2007-07-05 Hill's Pet Nutrition, Inc. Method for modifying gut flora in animals
DE102006001553A1 (de) 2006-01-05 2007-07-19 Ipc Process-Center Gmbh & Co. Teilchen mit darin enthaltener empfindlicher Komponente
DE102006001554A1 (de) 2006-01-05 2007-07-12 Ipc Process-Center Gmbh & Co. Micropellets für die Herstellung von Tiernahrungspellets
CA2636181A1 (en) 2006-01-11 2007-07-19 Attune Foods Probiotic food, process for its preparation and dietary regimen
US20070166295A1 (en) 2006-01-13 2007-07-19 Vet Solutions L.P. Anti-Diarrhea Preparations for Small Domestic Animals
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
MX2008009574A (es) 2006-02-01 2008-09-04 Nestec Sa Sistema y metodos nutricionales para aumentar la longevidad.
WO2007093619A1 (en) 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
US7960605B2 (en) 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
US20070231414A1 (en) 2006-03-29 2007-10-04 Kaneka Corporation Composition having bone resorption inhibition-related effect and method for inhibiting bone resorption
AU2007245002B2 (en) 2006-03-29 2012-05-03 Société des Produits Nestlé S.A. Dietary supplements containing probiotics
WO2007137808A1 (en) 2006-05-29 2007-12-06 University College Dublin, National University Of Ireland, Dublin Compositions comprising oligosaccharides for treating prion disease
PE20080453A1 (es) 2006-05-31 2008-05-29 Glaxo Group Ltd Derivados de fenil.oxi-fenil-pirimidinona en el tratamiento de malaria
WO2008019887A2 (en) 2006-08-18 2008-02-21 Organobalance Gmbh Probiotic microorganisms for the reduction of manure odor
US20080053490A1 (en) 2006-09-01 2008-03-06 Bausch & Lomb Incorporated Method for hydrating a contact lens
US20080107699A1 (en) 2006-10-25 2008-05-08 Mark Spigelman Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor
US8557764B2 (en) 2007-01-26 2013-10-15 The Regents Of The University Of Colorado, A Body Corporate Methods of modulating immune function
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
EP2124969A2 (en) 2007-02-01 2009-12-02 The Iams Company Method for decreasing inflammation and oxidative stress in mammals
RU2407401C2 (ru) 2007-02-13 2010-12-27 Общество С Ограниченной Ответственностью "Марс" Способ кормления собак
BRPI0809454A2 (pt) 2007-03-27 2014-09-09 Procter & Gamble Métodos e kits para a administração de probióticos
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
MX2011002735A (es) 2008-09-11 2011-04-12 Iams Company Alimento granulado para animales que tiene un nucleo basado en proteinas y metodos relacionados.
US8691303B2 (en) 2009-07-31 2014-04-08 The Iams Company Dusted animal food
EP2506717B1 (en) 2009-12-04 2015-03-25 PerkinElmer, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
US20120115798A1 (en) 2010-11-04 2012-05-10 Stefan Patrick Massimino Method for improving the immunity of a companion animal
FR2969496B1 (fr) 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
US20120283197A1 (en) 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
US20120282373A1 (en) 2011-05-02 2012-11-08 Ashok Premchand Luhadiya Compositions Comprising a Glucose Anti-Metabolite and Selenium
EP2877032A1 (en) 2012-07-25 2015-06-03 Agrofresh, Inc. Methods of handling avocados and system
US20140348986A1 (en) 2013-05-23 2014-11-27 The Iams Company Avocado Processing
HUE040141T2 (hu) 2013-05-23 2019-02-28 Iams Europe B V Kalóriamegvonás metabolikus hatásának utánzása glükóz-anti-metabolitok adagolásával emlõsben pozitív válaszreakció fokozására
US20140349002A1 (en) 2013-05-23 2014-11-27 The Iams Company Ingestible Compositions Containing Criollo Avocado Component
AU2014346382A1 (en) 2013-11-11 2016-06-16 Mars, Incorporated Processes for preparing a carbohydrate extract comprising mannoheptulose and compositions comprising same

Also Published As

Publication number Publication date
EP1885383A1 (en) 2008-02-13
US9404162B2 (en) 2016-08-02
AU2006253007A1 (en) 2006-12-07
US20090214499A1 (en) 2009-08-27
CA2607949C (en) 2012-09-25
US8034601B2 (en) 2011-10-11
AU2006253007B2 (en) 2012-12-20
EP1885383B1 (en) 2016-09-21
BRPI0611492A2 (pt) 2010-09-08
ES2607988T3 (es) 2017-04-05
JP4938006B2 (ja) 2012-05-23
US20060269534A1 (en) 2006-11-30
CA2607949A1 (en) 2006-12-07
BRPI0611492B1 (pt) 2021-10-13
WO2006130188A1 (en) 2006-12-07
JP2008541757A (ja) 2008-11-27
AR053805A1 (es) 2007-05-23

Similar Documents

Publication Publication Date Title
PL1885383T3 (pl) Kocie probiotyczne bifidobakterie
PL380590A1 (pl) Preparat probiotyczny
ATE512211T1 (de) Feline probiotische lactobacilli
PL1866551T3 (pl) Wkładka łącząca
IL187919A0 (en) 4c
AP2008004533A0 (en) Pharmaceutical combination
ZA200805147B (en) Solid preparation
EP1897558A4 (en) SOLID PREPARATION
HK1113990A1 (en) Wheelchair
EP1967097A4 (en) PILLOW
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
EP1937503A4 (en) DIFFERENTIAL
ZA200806320B (en) Diazepinones
DE602006021065D1 (en) Lithium-batteriepack
EP1880287A4 (en) NETWORKING OF TWO COMPANIES
ZA200804666B (en) Pharmaceutical combination
EP1946681A4 (en) PILLOW
GB0506832D0 (en) Oral insert
PL1933802T3 (pl) Smoczek
GB0520902D0 (en) Nanotubes
GB2423975B (en) Capsules
GB0509917D0 (en) Wheelchairs
GB2423974B (en) Making capsules
GB0520430D0 (en) Swallow scarer
TWM292347U (en) Pillow